Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Lung Cancer|Breast Cancer|Pancreatic Cancer|Head and Neck Cancer|Gastric Cancer
Interventions: DRUG: 2-deoxy-D-glucose (2DG)
Sponsor: Threshold Pharmaceuticals